Ing, S. W., Finkelman, R. D., He, P., Khan, A. A., Mannstadt, M.
, Rejnmark, L., Song, I., Takács, I. & Wu, Y. (2023).
A Phase I Randomized Trial of Once-Daily Versus Twice-Daily Recombinant Human Parathyroid Hormone (1-84) for Hypoparathyroidism.
JBMR Plus,
7(7), Article e10758.
https://doi.org/10.1002/jbm4.10758
Melicine, S., Billoir, P., Faille, D.
, Grove, E. L., Lê, M. P., Ajzenberg, N., Smadja, D. M. & Gendron, N. (2023).
Dabigatran-reversal failure using standard dose of idarucizumab: a systematic review and meta-analysis of cases.
Research and Practice in Thrombosis and Haemostasis,
7(5), Article 100201.
https://doi.org/10.1016/j.rpth.2023.100201
Andrade, C. A. S., Mahrouseh, N., Gabrani, J., Charalampous, P., Cuschieri, S., Grad, D. A., Unim, B., Mechili, E. A., Chen-Xu, J., Devleesschauwer, B., Isola, G., von der Lippe, E., Baravelli, C. M., Fischer, F.
, Weye, N., Balaj, M., Haneef, R., Economou, M., Haagsma, J. A. & Varga, O. (2023).
Inequalities in the burden of non-communicable diseases across European countries: a systematic analysis of the Global Burden of Disease 2019 study.
International Journal for Equity in Health,
22(1), Article 140.
https://doi.org/10.1186/s12939-023-01958-8